Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]

Documenti analoghi

• Agomelatine as monotherapy for major depression: an outpatient, open-label study
  di: Pecenak, Jan, et al.
  Pubblicazione: (2013)
• Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
  di: Fornaro, Michele, et al.
  Pubblicazione: (2013)
• A 10-Month, Open-Label Evaluation of Desvenlafaxine in Outpatients With Major Depressive Disorder
  di: Tourian, Karen A., et al.
  Pubblicazione: (2011)
• Duloxetine in the treatment of major depressive disorder: an open-label study
  di: Hudson, James I, et al.
  Pubblicazione: (2007)
• Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
  Pubblicazione: (2013)